AI-CVD vs iCAC Device

Direct competitors — feature-level head-to-head below. Comparability 85/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI-CVD

by HeartLung Corporation

iCAC Device

by Bunkerhill Health

AI Verdict

Both AI-CVD and iCAC Device are FDA-cleared AI tools that perform opportunistic screening for coronary artery calcium (CAC) from existing CT scans. While iCAC Device specializes in the detection and quantification of CAC, AI-CVD offers a broader suite of measurements, including other cardiac structures, epicardial fat, and major vessel sizing, extending its screening capabilities to multisystem diseases from both chest and abdominal CTs. Therefore, they are direct competitors for CAC assessment, with AI-CVD providing a more comprehensive cardiovascular and multisystem screening solution.

Choose AI-CVD if…

Choose AI-CVD if your institution requires a comprehensive, opportunistic screening platform that extends beyond just coronary artery calcium. This tool is ideal for identifying a wider range of hidden cardiovascular and multisystem risks, including cardiac chamber volumetry, aortic valve calcification, and epicardial fat analysis, from existing CT scans.

View AI-CVD →

Choose iCAC Device if…

Choose iCAC Device if your primary need is a highly focused and precise solution for detecting and quantifying coronary artery calcium from routine chest CT scans. This tool is best suited for seamless integration into existing radiology workflows to provide accurate Agatston unit scores and support cardiovascular risk stratification with a clear focus on CAC burden.

View iCAC Device →

When choosing between AI-CVD and iCAC Device, physicians should consider their desired scope of opportunistic screening. Both are FDA-cleared AI tools that leverage existing CT scans for early cardiovascular disease detection, eliminating the need for additional imaging or radiation. A key practical difference lies in their breadth of analysis. The iCAC Device is specifically designed for the detection and quantification of coronary artery calcium (CAC) from routine chest CTs, providing Agatston unit estimates and visual segmentations. This makes it ideal for practices primarily focused on a streamlined, dedicated CAC scoring solution.

In contrast, AI-CVD offers a more comprehensive, multisystem assessment. Beyond CAC scoring, it provides automated measurements for aortic wall and valve calcification, cardiac chamber volumetry, epicardial fat volumetry, and aorta/pulmonary artery sizing. This broader analytical capability allows for opportunistic screening of a wider range of cardiovascular and multisystem diseases from both chest and abdominal CT scans. Therefore, a physician seeking a more extensive, holistic screening platform that can identify multiple hidden health risks from existing CT data would likely find AI-CVD more suitable, while those prioritizing a focused, efficient CAC quantification tool may prefer the iCAC Device.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AI-CVD	iCAC Device
Pricing	Contact for pricing	Contact for pricing
Deployment	Cloud	Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

iCAC Device

Tool B explicitly details its integration capabilities with PACS, DICOM routers, and EHRs via the Carebricks platform, which are critical for seamless adoption in radiology workflows. While Tool A claims 'no workflow disruption,' Tool B provides more specific mechanisms for how it achieves this, suggesting a more thought-out integration strategy for end-users.

Clinical Value

AI-CVD

Tool A provides a significantly broader range of quantitative measurements beyond just Coronary Artery Calcium (CAC), including aortic and mitral valve calcification, cardiac chamber volumetry, epicardial fat volumetry, and aorta/pulmonary artery sizing. This comprehensive analysis from existing CT scans offers a more holistic view of cardiovascular and multisystem health, potentially identifying a wider array of hidden risks.

Pricing & Value

Tie

Both tools explicitly state 'Contact for pricing' and provide no further details on their cost structure or potential return on investment. Without transparent pricing information or publicly available value propositions that differentiate them financially, it is impossible to determine a winner in this dimension.

Enterprise Readiness

iCAC Device

Tool B explicitly outlines its deployment as Software as a Medical Device (SaMD) and details integration with critical enterprise systems like PACS, DICOM routers, and EHRs through its Carebricks platform. This clear articulation of interoperability and deployment strategy indicates a strong focus on fitting into existing hospital IT infrastructure, making it highly enterprise-ready.

Innovation

AI-CVD

Tool A demonstrates greater innovation by extending opportunistic screening beyond just Coronary Artery Calcium (CAC) to encompass a broader range of cardiovascular and multisystem diseases. Its ability to derive numerous quantitative measurements, including cardiac chamber volumetry, valve calcification, epicardial fat, and major artery sizing, from existing CT scans represents a more comprehensive and novel application of AI for early disease detection.

Support & Docs

Tie

Neither the provided structured facts nor readily available public information offers details regarding the level of customer support, available documentation, training resources, or service level agreements for either tool. Without this essential information, it is not possible to distinguish between them in terms of support and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AI-CVD	iCAC Device
Name	AI-CVD	iCAC Device
Company	HeartLung Corporation	Bunkerhill Health
Categories	Cardiology AI	Cardiology AI
Specialties	Cardiology, Pulmonology, Radiology	Cardiology, Radiology
Key Features (CAC Scoring)	Coronary Artery Calcium (CAC) scoring	Estimates presence and quantity of coronary artery calcium (CAC); Delivers exact and four-category quantitative estimates of CAC burden in Agatston units
Additional Cardiac Measurements	Aortic wall, aortic valve, and mitral valve calcium analysis; Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle); Epicardial fat volumetry; Aorta and pulmonary artery sizing	Not specified
Opportunistic Screening	Opportunistic screening from existing chest and abdominal CT scans	Supports opportunistic identification of CAC from existing CT scans

Videos

Demos, reviews, and walkthroughs featuring AI-CVD and iCAC Device.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary difference in the range of conditions or measurements detected by AI-CVD compared to the iCAC Device?

AI-CVD is an AI-powered quantitative imaging platform that performs opportunistic screening for cardiovascular and multisystem diseases, enabling early detection of hidden health risks such as coronary heart disease, heart failure, stroke, osteoporosis, liver steatosis, and diabetes. The iCAC Device is an AI algorithm primarily focused on detecting and quantifying coronary artery calcium from routine chest CT scans to aid in early cardiovascular disease detection.

Beyond Coronary Artery Calcium (CAC), what other specific cardiac and vascular measurements does each tool provide?

AI-CVD offers automated CT-derived anatomical and density-based measurements including aortic wall, aortic valve, and mitral valve calcium analysis, cardiac chamber volumetry, epicardial fat volumetry, and aorta and pulmonary artery sizing. It also includes lung attenuation analysis, liver attenuation analysis, and bone mineral density and muscle-fat composition. The iCAC Device's key features are centered on estimating the presence and quantity of coronary artery calcium.

What types of existing CT scans are compatible with each tool for analysis?

AI-CVD can perform opportunistic screening using existing chest and abdominal CT scans, without requiring additional imaging, radiation, contrast, or workflow disruption. The iCAC Device analyzes routine, non-contrast, non-gated chest CT scans for coronary artery calcium detection.

What specific quantitative outputs for Coronary Artery Calcium (CAC) does each tool provide?

The iCAC Device delivers exact and four-category quantitative estimates of CAC burden in Agatston units, along with a visual representation of estimated CAC segmentation. AI-CVD performs Coronary Artery Calcium (CAC) scoring as one of its key features.